Properties of fractionated chondroitin sulphate from ox nasal septa
about
Hyaluronic acid in human articular cartilage. Age-related changes in content and sizeProteoglycans of hyaline cartilage: Electron-microscopic studies on isolated moleculesDextran sulphate induced arthritis in rabbitsMolecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epitheliaPolysaccharides for colon targeted drug delivery.Structure and properties of an under-sulfated heparan sulfate proteoglycan synthesized by a rat hepatoma cell line.Electron microscopy of cartilage proteoglycans.Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbersEndocytosis of hyaluronan in rat Kupffer cells.Binding of hyaluronate and chondroitin sulphate to liver endothelial cells.Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells.A comparative study of the glycosaminoglycan-peptides obtained after degradation of cartilage proteoglycan by different proteinases, and their use in the characterization of different proteoglycans.Characterization of a chondroitin sulphate proteoglycan from ovine brain.Interpretation of osmotic pressure in solutions of one and two nondiffusible components.A comparative study of glycosaminoglycans in cultures of human, normal and malignant glial cells.The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis.A chondroitin sulphate proteoglycan from human cultured glial and glioma cells. Structural and functional properties.Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells.The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan.The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan heterogeneity and the pathway of proteolytic degradation.Formulation and evaluation of chondroitin sulphate tablets of aceclofenac for colon targeted drug delivery.Mode of degradation of the chondroitin sulphate proteoglycan in rat costal cartilageQuantitative analysis of hyaluronate in nanogram amounts.The distribution of sulphate residues in the chondroitin sulphate chainA novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells.The heterogeneity of the non-aggregating proteoglycans of the human intervertebral disc.Structure and interactions of proteoglycans in the extracellular matrix produced by cultured human fibroblasts.Cell-surface heparan sulfate and heparan-sulfate/chondroitin-sulfate hybrid proteoglycans of mouse mammary epithelial cells.Preformulation studies and characterization of proposed chondroprotective agents: glucosamine HCl and chondroitin sulfate.Conformational behavior of chondroitin and chondroitin sulfate in relation to their physical properties as inferred by molecular modeling.The molecular weight of chondroitin sulphate from human articular cartilage. Effect of age and of osteoarthritis.Metabolism in vitro of cartilage proteoglycans in rat (pre)chondrocytes from different embryonic regions.Changes in cartilage proteoglycans associated with calcification.A study of the interactions between monomeric tropocollagen and glycosaminoglycans.Formation of chondroitin sulphate proteoglycan in cartilage regenerated from free perichondrial graft.Aggregation of feline lymphoma cells by hyaluronic acid.Insolubilization of sodium chondroitin sulfate by forming a semi-interpenetrating polymer network with acrylic acid: A potential carrier for colon-specific drug deliveryControlled immobilization of chondroitin sulfate in polyacrylic acid networks
P2860
Q24529511-757CE250-68D0-4551-957F-F1857C64735EQ33282592-9D3F987E-B948-4091-A210-81744A317EC3Q33552619-61D8EC20-18BF-40C5-B9F8-00BFC347D61BQ33685700-88BA9A66-5A78-461E-8F9E-0846B5406CBBQ35806904-7BB64C78-7CF0-4A73-904B-0D7236F0AA7CQ36210188-2C220AA7-D137-434E-B66B-9FA3F7C23054Q36630734-77E4F578-8F2B-483B-AEFF-A4CD2A2649AAQ36806702-AA714F3A-C36D-4E8A-8269-141D7E0EEF15Q38326224-99B27747-8375-4B28-AC5F-D5FDDB68723EQ38351201-454D5D19-396A-4890-A6AE-8810D8736CBFQ38353299-79997A58-9EFA-4F60-BED3-6CA2B8744E3AQ39879849-01F29DB8-A097-42DF-BCEC-A549C6037A9CQ41251471-162C60EA-2ECF-41BE-A2E6-D0221EE8635DQ41484186-4FBCC5B9-6AAF-43BA-8126-C77BEE716FD2Q41565696-1D3E47B4-305B-43BE-B763-237F1D8436FAQ41817475-D18268F7-275E-4FCC-835C-633627A97F33Q41848440-1C68BCDF-D623-4286-9C4F-871A671899EAQ41861902-4DE955EE-54E8-45BC-8C23-68440FB3AB56Q41880730-A6B66F02-E210-4A03-84F3-F74CDC97E3DCQ41950765-BA5146E4-84A6-43C1-ACDF-984AF46FC036Q42037344-A15923CC-C3FF-461A-9C9F-17C1C1A0CA06Q42100927-7E690689-3E92-4B47-B9D1-EF7E684A7913Q42169279-90BB486E-FD5D-41F3-8FC5-173FCFBB40ACQ42242273-61D99909-06C5-47B7-AD75-C84A800A906EQ42559867-B9A2CCA6-5E0F-445E-8559-907AE3276D27Q42856003-C87D8FCD-33D8-479A-BAE5-C007DE581A15Q42866978-B19BD4DD-04FF-4A89-B0E9-91280C631DCDQ44202196-5A1FDC36-5220-4106-B276-1371613198B3Q44263298-D0C57BA2-0766-42F8-BB4A-9868B311761BQ44419586-436D06FC-83C6-4221-9B77-C326E13374E9Q44482117-3CFEE644-2BA8-4E9F-910B-74213AF04DC2Q45391119-04928574-43F5-45A3-8BB7-9E5A4097CCF0Q46275705-7E2DFE3D-28CA-43EE-880A-ABB8EAAA7893Q52950859-1C8FF609-1F47-4AF2-8E90-2B648C273164Q54345422-B63E55FA-A64C-46A1-BA12-E836763D7817Q55492688-0386D865-570E-4882-BF38-B193C8553CE0Q57342057-65B65F1D-B798-41B0-9102-92EB36D33D05Q57380509-B61C0907-B3D8-40FC-9D09-EBCA77073004
P2860
Properties of fractionated chondroitin sulphate from ox nasal septa
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
1971年论文
@zh
1971年论文
@zh-cn
name
Properties of fractionated chondroitin sulphate from ox nasal septa
@en
Properties of fractionated chondroitin sulphate from ox nasal septa
@nl
type
label
Properties of fractionated chondroitin sulphate from ox nasal septa
@en
Properties of fractionated chondroitin sulphate from ox nasal septa
@nl
prefLabel
Properties of fractionated chondroitin sulphate from ox nasal septa
@en
Properties of fractionated chondroitin sulphate from ox nasal septa
@nl
P2860
P356
P1433
P1476
Properties of fractionated chondroitin sulphate from ox nasal septa
@en
P2093
Wasteson A
P2860
P304
P356
10.1042/BJ1220477
P407
P577
1971-05-01T00:00:00Z